Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Linde NS"'
Autor:
Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA. uchidan@nhlbi.nih.gov.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. uchidan@nhlbi.nih.gov., Stasula U; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Germino-Watnick P; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Hinds M; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Le A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Chu R; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Berg A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Liu X; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Su L; Genomics Technology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wu X; Genomics Technology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Bonifacino A; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Hong SG; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Dunbar CE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Lanieri L; Magenta Therapeutics, Cambridge, MA, USA., Bhat A; Magenta Therapeutics, Cambridge, MA, USA., Palchaudhuri R; Magenta Therapeutics, Cambridge, MA, USA., Bennet B; Magenta Therapeutics, Cambridge, MA, USA., Hoban M; Magenta Therapeutics, Cambridge, MA, USA., Bertelsen K; Magenta Therapeutics, Cambridge, MA, USA., Olson LM; Magenta Therapeutics, Cambridge, MA, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute (NHLBI) / National Institute of Diabetes, and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, Maryland, MD, USA.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 12; Vol. 14 (1), pp. 6291. Date of Electronic Publication: 2023 Oct 12.
Autor:
Essawi K; Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Gizan, Saudi Arabia., Hakami W; Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Gizan, Saudi Arabia., Naeem Khan MB; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.; Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan., Martin R; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Zeng J; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Chu R; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA., Blobel GA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Gerdemann U; Boston Children's Hospital, Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Kean LS; Boston Children's Hospital, Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Maitland SA; Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA., Wolfe SA; Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA., Metais JY; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Bauer DE; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Apr 20; Vol. 29, pp. 483-493. Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023).
Autor:
Peslak SA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Chandra V; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Ryu B; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Bhardwaj SK; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Jiang J; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; CAS Engineering Laboratory for Nanozyme, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People's Republic of China., Rupon JW; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Throm RE; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Essawi K; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.; Department of Medical Laboratory Science, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20814, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20814, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20814, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Ferrara F; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Wielgosz M; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Abdulmalik O; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Hamagami N; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Germino-Watnick P; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Le A; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Chu R; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Hinds M; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Weiss MJ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Tong W; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institutes (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Blobel GA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Jan 31; Vol. 31, pp. 452-465. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).
Autor:
Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA. uchidan@nhlbi.nih.gov.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan., Ferrara F; Department of Hematology, St. Jude Children's Research Hospital (SJCRH), Memphis, TN 38105, USA., Drysdale CM; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., DiNicola J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Shibata Y; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Wielgosz M; Department of Hematology, St. Jude Children's Research Hospital (SJCRH), Memphis, TN 38105, USA., Kim YS; Department of Hematology, St. Jude Children's Research Hospital (SJCRH), Memphis, TN 38105, USA., Bauler M; Vector Development and Production Laboratory, SJCRH, Memphis, TN 38105, USA., Throm RE; Vector Development and Production Laboratory, SJCRH, Memphis, TN 38105, USA., Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20892, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20892, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD 20892, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA., Ryu B; Department of Hematology, St. Jude Children's Research Hospital (SJCRH), Memphis, TN 38105, USA.; Umoja Biopharma, 1920 Terry Ave., Seattle, WA 98101, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Apr 28; Vol. 13 (591).
Autor:
Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.; Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Li L; MaxCyte, Gaithersburg, MD, USA., Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Drysdale CM; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, MD, USA., Allen C; MaxCyte, Gaithersburg, MD, USA., Peshwa MV; MaxCyte, Gaithersburg, MD, USA., De Ravin SS; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA., Malech HL; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD, USA.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 Apr 20; Vol. 2 (4), pp. 100247. Date of Electronic Publication: 2021 Apr 20 (Print Publication: 2021).
Autor:
Hong SG; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute., Sato N; Molecular Imaging Program, National Cancer Institute., Legrand F; Human Eosinophil Section, Laboratory of Parasitic Diseases., Gadkari M; Laboratory of Immune System Biology, and., Makiya M; Human Eosinophil Section, Laboratory of Parasitic Diseases., Stokes K; Human Eosinophil Section, Laboratory of Parasitic Diseases., Howe KN; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases., Yu SJ; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute., Linde NS; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute., Clevenger RR; Animal Surgery and Resources Core, National Heart, Lung, and Blood Institute, and., Hunt T; Animal Surgery and Resources Core, National Heart, Lung, and Blood Institute, and., Hu Z; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Choyke PL; Molecular Imaging Program, National Cancer Institute., Dunbar CE; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute., Klion AD; Human Eosinophil Section, Laboratory of Parasitic Diseases., Franco LM; Laboratory of Immune System Biology, and.
Publikováno v:
Blood [Blood] 2020 Dec 03; Vol. 136 (23), pp. 2667-2678.
Autor:
Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Zeng J; Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Pediatrics, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, Massachusetts, USA., Wu Y; Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Pediatrics, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, Massachusetts, USA.; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Shen AH; Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Pediatrics, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, Massachusetts, USA., Pellin D; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Drysdale C; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Bonanno J; Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Pediatrics, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, Massachusetts, USA., Bonifacino AC; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, Maryland, USA., Krouse AE; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, Maryland, USA., Linde NS; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, Maryland, USA., Engels T; Translational Stem Cell Biology Branch, NHLBI, NIH, Bethesda, Maryland, USA., Donahue RE; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Leonard A; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA., Luk K; Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Porter SN; Department of Cell and Molecular Biology, Center for Advanced Genome Engineering, and., Lazzarotto CR; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Tsai SQ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Weiss MJ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Pruett-Miller SM; Department of Cell and Molecular Biology, Center for Advanced Genome Engineering, and., Wolfe SA; Department of Molecular, Cell and Cancer Biology, Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Bauer DE; Division of Hematology/Oncology, Boston Children's Hospital, Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Department of Pediatrics, Harvard Stem Cell Institute, Broad Institute, Harvard Medical School, Boston, Massachusetts, USA., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute (NHLBI)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2020 Dec 01; Vol. 130 (12), pp. 6677-6687.
Autor:
Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Mora JJH; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Drysdale C; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD., Bonifacino AC; Translational Stem Cell Biology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD., Krouse AE; Translational Stem Cell Biology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD., Linde NS; Translational Stem Cell Biology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD., Donahue RE; Translational Stem Cell Biology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda, MD., Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. Electronic address: johntis@mail.nih.gov., Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Publikováno v:
Experimental hematology [Exp Hematol] 2019 Jul; Vol. 75, pp. 21-25.e1. Date of Electronic Publication: 2019 Jun 05.
Autor:
Weichbrod RH; Chief, Animal Program Administration at the National Eye Institute, National Institutes of Health, Department of Health and Human Services., Blanks S; Director of Workforce Development at Seeking Equality, Empowerment, and Community for People with Developmental Disabilities (SEEC)., Plemons T; Chief, Operations Management at the National Eye Institute, National Institutes of Health, Department of Health and Human Services., Mallon D; Building 49 Central Animal Facility Manager at the National Eye Institute, National Institutes of Health, Department of Health and Human Services., Chinchilla J; Project Manager for the Building 49 Central Animal Facility with Priority One Services, Inc., Linde NS; Assistant Project Manager for the Building 49 Central Animal Facility with Priority One Services, Inc., Drake JB; Animal Care and Use Committee Coordinator at the National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services., Raber JM; Animal Program Director at the National Eye Institute and the National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services.
Publikováno v:
Laboratory animal science professional [Lab Animal Sci Prof] 2015 Dec; Vol. 3 (4), pp. 12-20. Date of Electronic Publication: 2015 Dec 04.
Autor:
Swearengen JR; National Biodefense Analysis and Countermeasures Center, Frederick, Maryland 21702, USA. swearengenj@nbacc.net, Vargas KJ, Tate MK, Linde NS
Publikováno v:
ILAR journal [ILAR J] 2010; Vol. 51 (2), pp. 120-6.